Title: Relationship between vulnerability to reinforcing effects of morphine and activity of the endogenous cholecystokinin system in Lewis and Fischer rats.
Journal: Addiction biology20120501
Title: Chronic stress induces transient spinal neuroinflammation, triggering sensory hypersensitivity and long-lasting anxiety-induced hyperalgesia.
Journal: Pain20100801
Title: Role of spinal cholecystokinin in neuropathic pain after spinal cord hemisection in rats.
Journal: Neuroscience letters20091025
Title: Pain management by a new series of dual inhibitors of enkephalin degrading enzymes: long lasting antinociceptive properties and potentiation by CCK2 antagonist or methadone.
Journal: Pain20030701
Title: The neurochemical effects of anxiolytic drugs are dependent on rearing conditions in Fawn-Hooded rats.
Journal: Progress in neuro-psychopharmacology & biological psychiatry20030501
Title: CI-988 inhibits growth of small cell lung cancer cells.
Journal: The Journal of pharmacology and experimental therapeutics20011201
Title: Enhancement of the effects of a complete inhibitor of enkephalin-catabolizing enzymes, RB 101, by a cholecystokinin-B receptor antagonist in diabetic rats.
Journal: British journal of pharmacology20010501
Title: Role of cholecystokinin in the reduction of endomorphin-2-induced antinociception in diabetic mice.
Journal: European journal of pharmacology20010323
Title: The role of spinal cholecystokinin B receptors in thermal allodynia and hyperalgesia in diabetic mice.
Journal: Brain research20010223
Title: Synthesis and SAR of new 5-phenyl-3-ureido-1,5-benzodiazepines as cholecystokinin-B receptor antagonists.
Journal: Journal of medicinal chemistry20001005
Title: Characterization of the binding of a novel radioligand to CCKB/gastrin receptors in membranes from rat cerebral cortex.
Journal: British journal of pharmacology19990301
Title: Second generation 'peptoid' CCK-B receptor antagonists: identification and development of N-(adamantyloxycarbonyl)-alpha-methyl-(R)-tryptophan derivative (CI-1015) with an improved pharmacokinetic profile.
Journal: Journal of medicinal chemistry19980101
Title: Cholecystokinin B antagonists. Synthesis and quantitative structure-activity relationships of a series of C-terminal analogues of CI-988.
Journal: Bioorganic & medicinal chemistry19961001
Title: Pharmacological characterization of a Chinese hamster ovary cell line transfected with the human CCK-B receptor gene.
Journal: Neuropeptides19960801
Title: Role of N- and C-terminal substituents on the CCK-B agonist-antagonist pharmacological profile of Boc-Trp-Phg-Asp-Nal-NH2 derivatives.
Journal: Bioorganic & medicinal chemistry19960401
Title: His381 of the rat CCKB receptor is essential for CCKB versus CCKA receptor antagonist selectivity.
Journal: European journal of pharmacology19960118
Title: Pharmacological profile of (R)-1-[2,3-dihydro-1-(2'-methylphenacyl)-2-oxo- 5-phenyl-1H-1,4-benzodiazepin-3-yl]-3-(3-methylphenyl)urea (YM022), a new potent and selective gastrin/cholecystokinin-B receptor antagonist, in vitro and in vivo.
Journal: The Journal of pharmacology and experimental therapeutics19940501
Title: The CCK-B antagonist CI988 enhances the reflex-depressive effect of morphine in axotomized rats.
Journal: Neuroreport19940224
Title: Development of a class of selective cholecystokinin type B receptor antagonists having potent anxiolytic activity.
Journal: Proceedings of the National Academy of Sciences of the United States of America19900901
